Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

被引：37
|
作者：
Lee, Sung Won [1 ,2 ]
Choi, Jonggi [3 ]
Kim, Seung Up [4 ,5 ]
Lim, Young-Suk [3 ]
机构：
[1] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Catholic Univ, Liver Res Ctr, Seoul, South Korea
[3] Univ Ulsan, Liver Ctr, Asan Med Ctr, Dept Gastroenterol,Coll Med, Seoul, South Korea
[4] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2021年 / 27卷 / 03期
关键词：
Entecavir; Tenofovir; Hepatitis B; Carcinoma; Hepatocellular; Efficacy; Outcome; DISOPROXIL FUMARATE; RISK; CIRRHOSIS;
D O I：
10.3350/cmh.2021.0179
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short to intermediate-term efficacy, including virologic, biochemical, serologic, and histologic responses. However, huge controversies regarding the antiviral efficacy of ETV and TDF in preventing the development of hepatocellular carcinoma (HCC) still exist. In this review, we summarized recent studies that compared the treatment efficacy of ETV and TDF in terms of HCC development.
引用
收藏
页码：402 / 412
页数：11
相关论文
共 50 条
  • [21] Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
    Hsu, Yao-Chun
    Ho, Hsiu-J.
    Lee, Teng-Yu
    Huang, Yen-Tsung
    Wu, Ming-Shiang
    Lin, Jaw-Town
    Wu, Chun-Ying
    El-Serag, Hashem B.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 543 - 551
  • [22] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B Reply
    Choi, Jonggi
    Ko, Min Jung
    Lim, Young-Suk
    JAMA ONCOLOGY, 2019, 5 (06) : 916 - 917
  • [23] The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus
    Kramer, Jennifer R.
    Richardson, Peter A.
    Kim, Hyunseok
    Hsu, Yao-Chun
    Kanwal, Fasiha
    El-Serag, Hashem B.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 1111 - 1113
  • [24] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir?
    Kamal, Faisal
    Khan, Muhammad Ali
    GASTROENTEROLOGY, 2020, 158 (08) : 2311 - 2312
  • [25] Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis-authors' reply
    Chiu, Sherry Yueh-Hsia
    Chang, Kuo-Chin
    Hu, Tsung-Hui
    Chien, Rong-Nan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1042 - 1043
  • [26] ENTECAVIR VS. TENOFOVIR IN PREVENTION OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B: SYSTEMATIC REVIEW AND META-ANALYSIS
    Kamal, Faisal
    Khan, Muhammad Ali
    Marella, Hemnishil K.
    Bayoumi, Mahmoud
    Arshad, Hafiz Muhammad Sharjeel
    Mude, Pooja J.
    Waters, Bradford
    Nair, Satheesh
    GASTROENTEROLOGY, 2020, 158 (06) : S1289 - S1289
  • [27] Hepatitis B: Tenofovir is superior than Entecavir for treating Patients with Hepatocellular Carcinoma
    Lorenz, Judith
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (08):
  • [28] Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis
    Liu, Shi-Jia
    Zhang, Xiao
    Yan, Lun-Jie
    Wang, Han-Chao
    Ding, Zi-Niu
    Liu, Hui
    Pan, Guo-Qiang
    Han, Cheng-Long
    Tian, Bao-Wen
    Dong, Zhao-Ru
    Wang, Dong-Xu
    Yan, Yu-Chuan
    Li, Tao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (02)
  • [29] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1083 - 1092
  • [30] Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
    Tseng, Cheng-Hao
    Hsu, Yao-Chun
    Chen, Tzu-Haw
    Ji, Fanpu
    Chen, I-Sung
    Tsai, Ying-Nan
    Hai, Hoang
    Le Thi Thanh Thuy
    Hosaka, Tetsuya
    Sezaki, Hitomi
    Borghi, John A.
    Cheung, Ramsey
    Enomoto, Masaru
    Nguyen, Mindie H.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (12): : 1039 - 1052
12345